Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bemarituzumab
bemarituzumab
Amgen's promising gastric cancer drug makes good on Five Prime potential with FDA's breakthrough nod
Endpoints
Tue, 04/20/21 - 11:13 am
Amgen
clinical trials
gastric cancer
bemarituzumab
FDA
Why Five Prime Therapeutics Stock Gained 312% in November
Motley Fool
Tue, 12/8/20 - 10:46 am
Five Prime Therapeutics
stomach cancer
bemarituzumab
Five Prime looks to turn a corner
EP Vantage
Wed, 11/11/20 - 10:55 am
Five Prime Therapeutics
stomach cancer
bemarituzumab
First Patient Dosed in Ph III Trial of Bemarituzumab for Advanced Gastric and Gastroesophageal Junction Cancers
CP Wire
Mon, 10/1/18 - 09:38 am
Five Prime
Zai Lab
bemarituzumab
gastric cancer
First Patient Dosed in Ph III Trial of Bemarituzumab for Advanced Gastric and Gastroesophageal Junction Cancers
Mon, 10/1/18 - 09:38 am
Five Prime
Zai Lab
bemarituzumab
gastric cancer